Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes
dc.contributor.author | Keegan, Catherine E. | en_US |
dc.contributor.author | Hutz, Janna E. | en_US |
dc.contributor.author | Krause, Andrea S. | en_US |
dc.contributor.author | Koehler, Katrin | en_US |
dc.contributor.author | Metherell, Louise A. | en_US |
dc.contributor.author | Boikos, Sosipatros | en_US |
dc.contributor.author | Stergiopoulos, Sotirios | en_US |
dc.contributor.author | Clark, Adrian J. L. | en_US |
dc.contributor.author | Stratakis, Constantine A. | en_US |
dc.contributor.author | Huebner, Angela | en_US |
dc.contributor.author | Hammer, Gary D. | en_US |
dc.date.accessioned | 2010-06-01T20:51:01Z | |
dc.date.available | 2010-06-01T20:51:01Z | |
dc.date.issued | 2007-08 | en_US |
dc.identifier.citation | Keegan, Catherine E.; Hutz, Janna E.; Krause, Andrea S.; Koehler, Katrin; Metherell, Louise A.; Boikos, Sosipatros; Stergiopoulos, Sotirios; Clark, Adrian J. L.; Stratakis, Constantine A.; Huebner, Angela; Hammer, Gary D. (2007). "Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes." Clinical Endocrinology 67(2): 168-174. <http://hdl.handle.net/2027.42/73948> | en_US |
dc.identifier.issn | 0300-0664 | en_US |
dc.identifier.issn | 1365-2265 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73948 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17466001&dopt=citation | en_US |
dc.description.abstract | Objective ACTH resistance is a feature of several human syndromes with known genetic causes, including familial glucocorticoid deficiency (types 1 and 2) and triple A syndrome. However, many patients with ACTH resistance lack an identifiable genetic aetiology. The human homolog of the Acd gene, mutated in a mouse model of adrenal insufficiency, was sequenced in 25 patients with a clinical diagnosis of familial glucocorticoid deficiency or triple A syndrome. Design A 3·4 kilobase genomic fragment containing the entire ACD gene was analysed for mutations in all 25 patients. Setting Samples were obtained by three investigators from different institutions. Patients The primary cohort consisted of 25 unrelated patients, primarily of European or Middle Eastern descent, with a clinical diagnosis of either familial glucocorticoid deficiency (FGD) or triple A syndrome. Patients lacked mutations in other genes known to cause ACTH resistance, including AAAS for patients diagnosed with triple A syndrome and MC2R and MRAP for patients diagnosed with familial glucocorticoid deficiency. Thirty-five additional patients with adrenal disease phenotypes were added to form an expanded cohort of 60 patients. Measurements Identification of DNA sequence changes in the ACD gene in the primary cohort and analysis of putative ACD haplotypes in the expanded cohort. Results No disease-causing mutations were found, but several novel single nucleotide polymorphisms (SNPs) and two putative haplotypes were identified. The overall frequency of SNPs in ACD is low compared to other gene families. Conclusions No mutations were identified in ACD in this collection of patients with ACTH resistance phenotypes. However, the newly identified SNPs in ACD should be more closely examined for possible links to disease. | en_US |
dc.format.extent | 120019 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | © 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd | en_US |
dc.title | Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Department of Pediatrics, Division of Genetics, University of Michigan, Ann Arbor MI, USA, | en_US |
dc.contributor.affiliationum | ** Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor MI, USA | en_US |
dc.contributor.affiliationother | † Children's Hospital, Technical University Dresden, Dresden, Germany, | en_US |
dc.contributor.affiliationother | † Department of Endocrinology, William Harvey Research Institute, Barts & the London School of Medicine and Dentistry, Queen Mary University of London, West Smithfield, London, UK, | en_US |
dc.contributor.affiliationother | § Section on Endocrinology and Genetics, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda MD, USA, | en_US |
dc.contributor.affiliationother | ¶ Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes and | en_US |
dc.identifier.pmid | 17466001 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73948/1/j.1365-2265.2007.02855.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2265.2007.02855.x | en_US |
dc.identifier.source | Clinical Endocrinology | en_US |
dc.identifier.citedreference | Beamer, W.G., Sweet, H.O., Bronson, R.T., Shire, J.G., Orth, D.N. & Davisson, M.T. ( 1994 ) Adrenocortical dysplasia: a mouse model system for adrenocortical insufficiency. Journal of Endocrinology, 141, 33 – 43. | en_US |
dc.identifier.citedreference | Keegan, C.E., Hutz, J.E., Else, T., Adamska, M., Shah, S.P., Kent, A.E., Howes, J.M., Beamer, W.G. & Hammer, G.D. ( 2005 ) Urogenital and caudal dysgenesis in adrenocortical dysplasia ( acd ) mice is caused by a splicing mutation in a novel telomeric regulator. Human Molecular Genetics, 14, 113 – 123. | en_US |
dc.identifier.citedreference | Liu, D., Safari, A., O’Connor, M.S., Chan, D.W., Laegeler, A., Qin, J. & Songyang, Z. ( 2004 ) PTOP interacts with POT1 and regulates its localization to telomeres. Nature Cell Biology, 6, 673 – 680. | en_US |
dc.identifier.citedreference | Ye, J.Z., Hockemeyer, D., Krutchinsky, A.N., Loayza, D., Hooper, S.M., Chait, B.T. & de Lange, T. ( 2004 ) POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes and Development, 18, 1649 – 1654. | en_US |
dc.identifier.citedreference | Keegan, C.E. & Hammer, G.D. ( 2002 ) Recent insights into organogenesis of the adrenal cortex. Trends in Endocrinology and Metabolism, 13, 200 – 208. | en_US |
dc.identifier.citedreference | Else, T. & Hammer, G.D. ( 2005 ) Genetic analysis of adrenal absence: agenesis and aplasia. Trends in Endocrinology and Metabolism, 16, 458 – 468. | en_US |
dc.identifier.citedreference | Clark, A.J. & Weber, A. ( 1998 ) Adrenocorticotropin insensitivity syndromes. Endocrine Reviews, 19, 828 – 843. | en_US |
dc.identifier.citedreference | Lin, L., Hindmarsh, P.C., Metherell, L.A., Alzyoud, M., Al-Ali, M., Brain, C.E., Clark, A.J., Dattani, M.T. & Achermann, J.C. ( 2007 ) Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia. Clinical Endocrinology, 66, 205 – 210. | en_US |
dc.identifier.citedreference | Metherell, L.A., Chapple, J.P., Cooray, S., David, A., Becker, C., Ruschendorf, F., Naville, D., Begeot, M., Khoo, B., Nurnberg, P., Huebner, A., Cheetham, M.E. & Clark, A.J. ( 2005 ) Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nature Genetics, 37, 166 – 170. | en_US |
dc.identifier.citedreference | Prpic, I., Huebner, A., Persic, M., Handschug, K. & Pavletic, M. ( 2003 ) Triple A syndrome: genotype-phenotype assessment. Clinical Genetics, 63, 415 – 417. | en_US |
dc.identifier.citedreference | Brooks, B.P., Kleta, R., Stuart, C., Tuchman, M., Jeong, A., Stergiopoulos, S.G., Bei, T., Bjornson, B., Russell, L., Chanoine, J.P., Tsagarakis, S., Kalsner, L. & Stratakis, C. ( 2005 ) Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000–05. Clinical Genetics, 68, 215 – 221. | en_US |
dc.identifier.citedreference | Tullio-Pelet, A., Salomon, R., Hadj-Rabia, S., Mugnier, C., de Laet, M.H., Chaouachi, B., Bakiri, F., Brottier, P., Cattolico, L., Penet, C., Begeot, M., Naville, D., Nicolino, M., Chaussain, J.L., Weissenbach, J., Munnich, A. & Lyonnet, S. ( 2000 ) Mutant WD-repeat protein in triple A syndrome. Nature Genetics, 26, 332 – 335. | en_US |
dc.identifier.citedreference | Handschug, K., Sperling, S., Yoon, S.J., Hennig, S., Clark, A.J. & Huebner, A. ( 2001 ) Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Human Molecular Genetics, 10, 283 – 290. | en_US |
dc.identifier.citedreference | Huebner, A., Kaindl, A.M., Knobeloch, K.P., Petzold, H., Mann, P. & Koehler, K. ( 2004 ) The triple A syndrome is due to mutations in ALADIN, a novel member of the nuclear pore complex. Endocrine Research, 30, 891 – 899. | en_US |
dc.identifier.citedreference | Krumbholz, M., Koehler, K. & Huebner, A. ( 2006 ) Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome – shedding light on an unexpected splice mutation. Biochemistry and Cell Biology, 84, 243 – 249. | en_US |
dc.identifier.citedreference | Hutz, J.E., Krause, A.S., Achermann, J.C., Vilain, E., Tauber, M., Lecointre, C., McCabe, E.R., Hammer, G.D. & Keegan, C.E. ( 2006 ) IMAGe association and congenital adrenal hypoplasia: No disease-causing mutations found in the ACD gene. Molecular Genetics and Metabolism, 88, 66 – 70. | en_US |
dc.identifier.citedreference | 17 The International HapMap Consortium ( 2003 ) The International HapMap Project. Nature, 426, 789 – 796. | en_US |
dc.identifier.citedreference | Savage, S.A., Stewart, B.J., Eckert, A., Kiley, M., Liao, J.S. & Chanock, S.J. ( 2005 ) Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint. Human Mutation, 26, 343 – 350. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.